203 related articles for article (PubMed ID: 32385059)
1. Chest radiograph findings in children aged 2-59 months hospitalised with community-acquired pneumonia, prior to the introduction of pneumococcal conjugate vaccine in India: a prospective multisite observational study.
Awasthi S; Rastogi T; Mishra N; Chauhan A; Mohindra N; Shukla RC; Agarwal M; Pandey CM; Kohli N; Study Group C
BMJ Open; 2020 May; 10(5):e034066. PubMed ID: 32385059
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of 13-valent pneumococcal conjugate vaccine on radiological primary end-point pneumonia among cases of severe community acquired pneumonia in children: A prospective multi-site hospital-based test-negative study in Northern India.
Awasthi S; Kohli N; Agarwal M; Pandey CM; Rastogi T; Pandey AK; Roy C; Mishra K; Verma N; Kumar CB; Jain PK; Yadav R; Dhasmana P; Chauhan A; Mohindra N; Shukla RC
PLoS One; 2022; 17(12):e0276911. PubMed ID: 36520841
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan.
Takeuchi N; Naito S; Ohkusu M; Abe K; Shizuno K; Takahashi Y; Omata Y; Nakazawa T; Takeshita K; Hishiki H; Hoshino T; Sato Y; Ishiwada N
Epidemiol Infect; 2020 Apr; 148():e91. PubMed ID: 32299523
[TBL] [Abstract][Full Text] [Related]
4. Role of chest X-ray in predicting outcome of acute severe pneumonia.
Bharti B; Kaur L; Bharti S
Indian Pediatr; 2008 Nov; 45(11):893-8. PubMed ID: 19029561
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of Hypoxic Community-Acquired Pneumonia in Children Under 5 Years of Age: An Observational Study in Northern India.
Awasthi S; Rastogi T; Pandey AK; Roy C; Mishra K; Verma N; Kumar CB; Jain PK; Yadav R; Chauhan A; Mohindra N; Shukla RC; Agarwal M; Pandey CM; Kohli N
Front Pediatr; 2021; 9():790109. PubMed ID: 35223708
[TBL] [Abstract][Full Text] [Related]
6. Incidence of community acquired pneumonia in children aged 2-59 months of age in Uttar Pradesh and Bihar, India, in 2016: An indirect estimation.
Awasthi S; Pandey CM; Verma T; Mishra N;
PLoS One; 2019; 14(3):e0214086. PubMed ID: 30893356
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of community-acquired pneumonia hospitalisations before the introduction of pneumococcal conjugate vaccine into Polish National Immunisation Programme (2009-2016): A nationwide retrospective database analysis.
Gajewska M; Goryński P; Paradowska-Stankiewicz I; Lewtak K; Piotrowicz M; Urban E; Cianciara D; Wysocki MJ; Książek A; Izurieta P
Vaccine; 2020 Jan; 38(2):194-201. PubMed ID: 31653527
[TBL] [Abstract][Full Text] [Related]
8. Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children.
Angoulvant F; Levy C; Grimprel E; Varon E; Lorrot M; Biscardi S; Minodier P; Dommergues MA; Hees L; Gillet Y; Craiu I; Zenkhri F; Dubos F; Guen CG; Launay E; Martinot A; Cohen R
Clin Infect Dis; 2014 Apr; 58(7):918-24. PubMed ID: 24532543
[TBL] [Abstract][Full Text] [Related]
9. Infection by Streptococcus pneumoniae in children with or without radiologically confirmed pneumonia.
Andrade DC; Borges IC; Vilas-Boas AL; Fontoura MSH; Araújo-Neto CA; Andrade SC; Brim RV; Meinke A; Barral A; Ruuskanen O; Käyhty H; Nascimento-Carvalho CM
J Pediatr (Rio J); 2018; 94(1):23-30. PubMed ID: 28668258
[TBL] [Abstract][Full Text] [Related]
10. Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children.
Ouldali N; Levy C; Minodier P; Morin L; Biscardi S; Aurel M; Dubos F; Dommergues MA; Mezgueldi E; Levieux K; Madhi F; Hees L; Craiu I; Gras Le Guen C; Launay E; Zenkhri F; Lorrot M; Gillet Y; Béchet S; Hau I; Martinot A; Varon E; Angoulvant F; Cohen R
JAMA Pediatr; 2019 Apr; 173(4):362-370. PubMed ID: 30715140
[TBL] [Abstract][Full Text] [Related]
11. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults.
Nelson JC; Jackson M; Yu O; Whitney CG; Bounds L; Bittner R; Zavitkovsky A; Jackson LA
Vaccine; 2008 Sep; 26(38):4947-54. PubMed ID: 18662735
[TBL] [Abstract][Full Text] [Related]
12. Lung Ultrasound is Comparable with Chest Roentgenogram for Diagnosis of Community-Acquired Pneumonia in Hospitalised Children.
Yadav KK; Awasthi S; Parihar A
Indian J Pediatr; 2017 Jul; 84(7):499-504. PubMed ID: 28337699
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal conjugate vaccines decrease community-acquired alveolar pneumonia with and without pleural effusion in children <60 months in Southern Israel, 2002-2016.
Triadou D; Givon-Lavi N; Greenberg D; Ben-Shimol S
Infect Dis (Lond); 2020 Mar; 52(3):186-195. PubMed ID: 31774020
[No Abstract] [Full Text] [Related]
14. Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules.
Lee HY; Hsieh YC; Liu CC; Huang YC; Chang KY; Chi H; Chang LY; Huang YC; Huang LM;
J Microbiol Immunol Infect; 2018 Apr; 51(2):199-206. PubMed ID: 29021105
[TBL] [Abstract][Full Text] [Related]
15. Prospective, population-based surveillance of the burden of Streptococcus pneumoniae in community-acquired pneumonia in older adults, Chrzanów County, Poland, 2010 to 2012.
Harat R; Alexander R; Gray S; Gutterman EM; Pluta J; Pride M; Shite S; Fijolek J; Kozub J
Pneumonol Alergol Pol; 2016; 84(2):95-103. PubMed ID: 27238167
[TBL] [Abstract][Full Text] [Related]
16. Nasopharyngeal carriage of Streptococcus pneumoniae serotypes among children in India prior to the introduction of pneumococcal conjugate vaccines: a cross-sectional study.
Sutcliffe CG; Shet A; Varghese R; Veeraraghavan B; Manoharan A; Wahl B; Chandy S; Sternal J; Khan R; Singh RK; Santosham M; Arora NK
BMC Infect Dis; 2019 Jul; 19(1):605. PubMed ID: 31291902
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.
Lucero MG; Nohynek H; Williams G; Tallo V; Simões EA; Lupisan S; Sanvictores D; Forsyth S; Puumalainen T; Ugpo J; Lechago M; de Campo M; Abucejo-Ladesma E; Sombrero L; Nissinen A; Soininen A; Ruutu P; Riley I; Mäkelä HP
Pediatr Infect Dis J; 2009 Jun; 28(6):455-62. PubMed ID: 19483514
[TBL] [Abstract][Full Text] [Related]
18. Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children.
Silva SR; Mello LM; Silva AS; Nunes AA
Rev Paul Pediatr; 2016 Dec; 34(4):418-424. PubMed ID: 27108092
[TBL] [Abstract][Full Text] [Related]
19. Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18.
Pick H; Daniel P; Rodrigo C; Bewick T; Ashton D; Lawrence H; Baskaran V; Edwards-Pritchard RC; Sheppard C; Eletu SD; Rose S; Litt D; Fry NK; Ladhani S; Chand M; Trotter C; McKeever TM; Lim WS
Thorax; 2020 Jan; 75(1):38-49. PubMed ID: 31594801
[TBL] [Abstract][Full Text] [Related]
20. Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study.
Langley JM; Kellner JD; Solomon N; Robinson JL; Le Saux N; McDonald J; Ulloa-Gutierrez R; Tan B; Allen U; Dobson S; Joudrey H
BMC Infect Dis; 2008 Sep; 8():129. PubMed ID: 18816409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
